A study on the clinical, biochemical and hormonal profile of polycystic ovary syndrome patients attending tertiary care hospital


  • Spandana J. C. Department of Obstetrics and Gynecology, K. S. Hegde Medical Academy, Mangalore, Karnataka, India
  • Prasanna Kumar Shetty K. Department of Obstetrics and Gynecology, K. S. Hegde Medical Academy, Mangalore, Karnataka, India
  • Prasanna Kumar Shetty K. Department of Obstetrics and Gynecology, K. S. Hegde Medical Academy, Mangalore, Karnataka, India




Body mass index, Hirsutism, Obese, Polycystic ovary syndrome


Background: Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorder of reproductive age affecting 5% to 10% of women worldwide. It is a heterogenous, multifactorial, complex genetic disorder. PCOS receives a considerable attention because of its high prevalence and metabolic, reproductive and cardiovascular consequences.

Methods: A cross sectional observation study of 100 PCOS patients was carried out between January 2014 to July 2015 in Gynaecology out-patient and Infertility OPD, Justice K. S. Hegde charitable hospital, Mangalore. The clinical, biochemical and hormonal profile of these patients were analysed and correlation was done between clinical features and biochemical and hormonal profile.

Results: The prevalence of PCOS was 6.3% in the Gynaecology out-patient visits and 37.14% among infertile women. Menstrual irregularity was the most common complaint accounting for 31% followed by infertility (23%). Elevated leutinizing hormone and elevated LH: FSH was significant in irregular menstrual group. The prevalence of metabolic syndrome in our study was 21.3%. Spearmans correlation between various clinical and laboratory parameters showed menstrual cycle and body mass index(BMI) had a fair positive correlation and was significant. WHR (waist hip ratio) showed 21 times risk for metabolic syndrome.

Conclusions: The study showed that most of our polycystic ovary syndrome subjects were hirsute, with central obesity and overweight or obese. Oligomenorrhea was the most common presentation. Among the various risk factors studied, WHR (waist hip ratio) showed 21 times risk for metabolic syndrome. Obese women with PCOS had more severe ovulatory dysfunction and need more attention for their appropriate management.


Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clini Endocrinol Metab. 2004;89(6):2745-9.

Practice committee of American Society of Reproductive Medicine. The evaluation and treatment of androgen excess. Fertil Steril. 2006;86: 173-80.

The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81:19-25.

Radon PA, McMahon MJ, Meyer WR. Impaired glucose tolerance in pregnant women with polycystic ovary syndrome. Obstet Gynecol. 1999;94:194-7.

Pasquali R, Gambineri A, Pagotto U. The impact of obesity on reproduction in women with polycystic ovary syndrome. BJOG. 2006;113:1148-59.

Lepor NE, Vogel RE. National Cholesterol Education Program Adult Treatment Panel III. Summary of the third report of the National Cholesterol Education Program Adult Treatment Panel III. Rev Cardiovas Med. 2001;2:160-5.

Escobar-Morreale H, Carmina E, Dewailly D, Gambineri A, Kelestimur F, Moghetti P, et al. Epidemiology, diagnosis and management of hirsutism: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society. Hum Reprod Update. 2012;19(2):207.

Ramanand SJ, Ramanand JB, Raparti GT, Ghanghas RR, Halasawadekar NR, Patil PT, et al. High sensitivity C-reactive protein (hs-CRP) and clinical characteristics, endocrine, metabolic profile in Indian women with PCOS: a correlation. Int J Reprod Contracept Obstet Gynecol. 2014;3(1):118-26.

Hussein B, and Alalaf S. Prevalence and characteristics of polycystic ovarian syndrome in a sample of infertile Kurdish women attending IVF infertility center in maternity teaching hospital of Erbil City.Open J Obstet Gynecol. 2013;10(3):577-85.

Muralidhara KD, Adhikari PM, Muralidhara DV. Indian Journal of Basic and Applied Medical Research. 2015;4(3):227-36.

Ogueh O, Zini M, Williams S, Ighere J. The Prevalence of Polycystic Ovary Morphology Among Women Attending a New Teaching Hospital in Southern Nigeria. Afr J Reprod Health. 2014; 18(1):161.

Ramanand SJ, Ramanand JB, Ghongane BB, Patwardhan MH, Patwardhan VM, Ghanghas R, et al. Correlation between serum adiponectin and clinical characteristics, biochemical parameters in Indian women 2with polycystic ovary syndrome. Indian J Endocr Metab. 2014;18:221-5.

Mandrelle K, Kamath MS, Bondu DJ, Chandy A, Aleyamma T, George K. Prevalence of metabolic syndrome in women with polycystic ovary syndrome attending an infertility clinic in a tertiary care hospital in south India. J Hum Reprod Sci. 2012;5(1):26-31.

Najem F, Elmehdawi R, Swalem A. Clinical and Biochemical Characteristics of Polycystic Ovary Syndrome in Benghazi- Libya; A Retrospective study. Libyan J Med. 2008;3(2):71-4.

Gill H, Chae SJ, Kim JJ, Choi YM, Hwang KR, Jee BC, et al. Clinical and biochemical characteristics of polycystic ovary syndrome in Korean women. Hum Reprod. 2008;23(8):1924-31.






Original Research Articles